KAREN MOORE: Open Payments
NPI 1487924650 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,401 in 56 payments from 13 companies in 2025. Trend: 2023 $798 · 2024 $771 · 2025 $1,401
Food & beverage: $1,401
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 17 | $369 |
| Phathom Pharmaceuticals, Inc. | 3 | $251 |
| Gilead Sciences, Inc. | 9 | $180 |
| Regeneron Healthcare Solutions, Inc. | 4 | $164 |
| Ardelyx, Inc. | 6 | $107 |
| ABBVIE INC. | 5 | $106 |
| GENZYME CORPORATION | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Ipsen Biopharmaceuticals, Inc | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: REZDIFFRA, VOQUEZNA, DUPIXENT, Livdelzi, IBSRELA, LINZESS, EOHILIA, IQIRVO.
Industry payments across IN — which companies pay providers there.
